March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Staging of Progression of Macular Telangiectasia Type 2 Using Power-Doppler Optical Coherence Tomography and Macular Pigment Optical Density
Author Affiliations & Notes
  • Eric K. Chin
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • Dae Yu Kim
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • Allan A. Hunter, III
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • Robert J. Zawadzki
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • John S. Werner
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • Susanna S. Park
    Ophthalmology & Vision Science, UC Davis Eye Center, Sacramento, California
  • Footnotes
    Commercial Relationships  Eric K. Chin, None; Dae Yu Kim, None; Allan A. Hunter, III, None; Robert J. Zawadzki, None; John S. Werner, None; Susanna S. Park, None
  • Footnotes
    Support  National Eye Institute (014743) and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1752. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eric K. Chin, Dae Yu Kim, Allan A. Hunter, III, Robert J. Zawadzki, John S. Werner, Susanna S. Park; Staging of Progression of Macular Telangiectasia Type 2 Using Power-Doppler Optical Coherence Tomography and Macular Pigment Optical Density. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1752.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Power-Doppler optical coherence tomography (Pd-OCT) provides non-invasive, three-dimensional images of the retinal vasculature by calculating phase changes in blood circulation. Macular pigment optical density (MPOD) is a non-invasive psychophysical procedure to quantitate the distribution of macular cartotenoids. These methods were used to evaluate eyes at various stages of progression of macular juxtafoveal telangiectasia type 2 (MacTel) to better understand the pathogenesis and progression of this condition.

Methods: : Nine eyes (five subjects) with MacTel and best corrected visual acuity (BCVA) of 20/100 or better were imaged by Pd-OCT. Clinical staging of MacTel was performed based on fundus photography, fluorescein angiography, and OCT. MPOD was measured using heterochromic flicker photometry in six eyes with BCVA of 20/40 or better.

Results: : Median BCVA was 20/25. One eye diagnosed clinically with Stage 1 MacTel (i.e. non-proliferative deep capillary stage) had subtle punctate vascular signal confined to the outer aspect of the outer plexiform layer on Pd-OCT. Two eyes with Stage 2 MacTel (i.e. superficial capillary stage of disease) showed oblique vascular signal extending into deeper layers. Among three eyes with Stage 3 MacTel (i.e. subinternal limiting membrane and foveal stage of disease), progressive disruption of outer retinal morphology with superficial retinal vasculature piercing into deeper layers was observed. Three eyes with Stage 4 MacTel (i.e. proliferative disease stage) showed photoreceptor disruption with retinal vascular channels connecting the superficial and deep retinal layers, and extending into the subretinal space forming retinal-choroidal anastomosis similar to neovascularization associated with retinal angiomatous proliferation. MPOD distribution was unremarkable in three eyes with Stage 1 to 2 disease; three eyes with Stage 3 to 4 MacTel had loss of foveal MPOD when compared to age-matched controls.

Conclusions: : Pd-OCT imaging is useful for non-invasively visualizing the progression of vascular abnormalities associated with MacTel. Early stages of the disease are characterized by penetration of the superficial retinal capillaries into the deeper retinal layers, subsequently leading to retinal-choroidal anastomosis in more advanced disease. The central depletion of MPOD is a common finding associated with MacTel, but may be absent in eyes with early stages of this condition.

Keywords: macula/fovea • imaging/image analysis: clinical • macular pigment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×